Accelerated approval history

Accelerated approval history

Studies reviewed
Product Indication Approved Company (total patients) (A)
Arimidex anastrozole Adjuvant treatment for hormone receptor-positive early breast cancer 9/5/02 AstraZeneca 1 (9,366)
Bexxar tositumomab

Read the full 281 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE